Fabrication of iron oxide@MOF-808 as a sorbent for magnetic solid phase extraction of benzoylurea insecticides in tea beverages and juice samples.

A novel magnetic metal organic framework composite (Fe3O4@MOF-808) was synthesized by a facile solvothermal method and applied as an adsorbent for the magnetic solid phase extraction (MSPE) of benzoylurea insecticides (BUs) from tea beverages and juice samples. The prepared materials were characterized using scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FT-IR), X-ray diffractometry (XRD), vibrating sample magnetometry measurements and N2 adsorption-desorption experiments. The adsorption (adsorbent amount, extraction time and pH) and elution (elution solvent, elution volume and time) parameters were investigated in detail. Under the optimized experimental conditions, Fe3O4@MOF-808 exhibited simpler and better reusability than commercial C18, with an equivalent adsorption effect. Notably, π-π interactions, hydrophobic interactions and hydrogen bonding interactions contributed to the good adsorption of BUs by Fe3O4@MOF-808. Finally, a simple and sensitive method was established using Fe3O4@MOF-808-based MSPE coupled with high-performance liquid chromatography (HPLC). It provided low limits of detection (0.04-0.15 ng/mL), wide linear ranges (0.15-50 ng/mL) and satisfactory recoveries (84.6-98.3%). The proposed method was successfully applied for the fast and sensitive determination of BUs in tea beverages and juice samples.

Fluorescence and Magnetic Resonance Dual-Modality Imaging-Guided Photothermal and Photodynamic Dual-Therapy with Magnetic Porphyrin-Metal Organic Framework Nanocomposites.

Phototherapy shows some unique advantages in clinical application, such as remote controllability, improved selectivity, and low bio-toxicity, than chemotherapy. In order to improve the safety and therapeutic efficacy, imaging-guided therapy seems particularly important because it integrates visible information to speculate the distribution and metabolism of the probe. Here we prepare biocompatible core-shell nanocomposites for dual-modality imaging-guided photothermal and photodynamic dual-therapy by the in situ growth of porphyrin-metal organic framework (PMOF) on Fe3O4@C core. Fe3O4@C core was used as T2-weighted magnetic resonance (MR) imaging and photothermal therapy (PTT) agent. The optical properties of porphyrin were well remained in PMOF, and PMOF was therefore selected for photodynamic therapy (PDT) and fluorescence imaging. Fluorescence and MR dual-modality imaging-guided PTT and PDT dual-therapy was confirmed with tumour-bearing mice as model. The high tumour accumulation of Fe3O4@C@PMOF and controllable light excitation at the tumour site achieved efficient cancer therapy, but low toxicity was observed to the normal tissues. The results demonstrated that Fe3O4@C@PMOF was a promising dual-imaging guided PTT and PDT dual-therapy platform for tumour diagnosis and treatment with low cytotoxicity and negligible in vivo toxicity.